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Abstract
Background: Postprandial accumulation of gastric secretions in the proximal stomach above the meal adjacent to
the esophagogastric junction (EGJ), referred to as the ‘acid pocket’, has been proposed as a pathophysiological factor
in gastro-esophageal reflux disease (GERD) and as a target for GERD treatment. This study assessed the effect of proton
pump inhibitor (PPI) therapy on the volume, distribution and acidity of gastric secretions in GERD and healthy
subjects (HS).
Methods: A randomized, double blind, cross-over study in 12 HS and 12 GERD patients pre-treated with
40 mg pantoprazole (PPI) or placebo b.i.d. was performed. Postprandial secretion volume (SV), formation of a
secretion layer and contact between the layer and the EGJ were quantified by Magnetic Resonance Imaging
(MRI). Multi-channel pH-monitoring assessed intragastric pH.
Results: A distinct layer of undiluted acid secretion was present on top of gastric contents in almost all participants on
and off high-dose acid suppression. PPI reduced SV (193 ml to 100 ml, in HS, 227 ml to 94 ml in GERD; p < 0.01) and
thickness of the acid layer (26 mm to 7 mm, 36 mm to 9 mm respectively, p < 0.01). No differences in secretion volume
or layer thickness were observed between groups; however, off treatment, contact time between the secretion layer
and EGJ was 2.6 times longer in GERD compared to HS (p = 0.012). This was not the case on PPI.
Conclusions: MRI can visualize and quantify the volume and distribution dynamics of gastric secretions that form a
layer in the proximal stomach after ingestion of a liquid meal. The secretion volume and the secretion layer on top of
gastric contents is similar in GERD patients and HS; however contact between the layer of undiluted secretion and the
EGJ is prolonged in patients. High dose PPI reduced secretion volume by about 50 % and reduced contact time
between secretion and EGJ towards normal levels.
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Background
Postprandial accumulation of acid secretion in the prox-
imal stomach above the meal adjacent to the esophago-
gastric junction (EGJ), referred to as the “acid pocket”,
has been proposed as a pathophysiological factor in gas-
tro-esophageal reflux disease (GERD) [1–4] and a target for
GERD treatment [5–9]. The acid pocket is described in pH
pull-through studies as a region of unbuffered gastric acid
(>2pH drop to below pH 4) in close proximity to the EGJ
[3]. This can be visualized also as a layer of gastric
secretion in the proximal stomach on the surface of the
meal by γ-scintigraphy and Magnetic Resonance Imaging
(MRI) [10–13]. Studies combining pH-monitoring and γ-
scintigraphy have shown that the acid pocket is the source
of acid reflux early after meal ingestion [1, 7, 12]. Moreover
the proximal border of the acid pocket has been shown to
encroach on the EGJ in GERD patients such that acid
secretions contact the distal esophageal mucosa. This
phenomenon has been associated with the presence
of reflux esophagitis and Barrett metaplasia [1–4].
One previous MRI study has shown that acid suppres-
sion by PPI reduces gastric content volume after meals
in healthy volunteers [14]; however, simple volume mea-
surements cannot differentiate between effects of PPI on
gastric secretion and gastric emptying. Moreover if the
acid pocket hypothesis is correct then it is not necessar-
ily increased secretion volume but rather the abnormal
distribution of unbuffered gastric secretions at the EGJ
that increases the risk of acid reflux and mucosal disease
in GERD patients.
The first objective of this study was to test the hy-
pothesis that, compared to healthy subjects, there is
abnormal distribution of gastric secretion in GERD
patients that leads to prolonged contact between un-
buffered acid and the EGJ after the meal. The second
objective was to complete a randomized, placebo-
controlled trial to document the effects of PPI on the
volume, distribution and acidity of the gastric secre-
tion layer and how this impacts on gastro-esophageal
reflux after the meal.
Methods
This clinical study was approved by the local ethics com-
mittee and registered at ClinicalTrial.gov (NCT01212614).
Written informed consent was obtained prior to inclusion.
Study design and test meal
Healthy subjects (HS) and GERD patients without large
hiatus hernia were investigated in a randomized, double
blind, crossover, placebo controlled study performed at
the University of Zurich and the Klinik Stephanshorn,
St.Gallen, Switzerland, from December 2010 to December
2011. For study participant allocation, a computer-
generated list of the study sequence was generated by an
investigator with no clinical involvement in the trial
(DM). Participants and investigators were blinded to
randomization during data acquisition and analysis.
The pantoprazole and placebo were in capsule form and
identical in appearance. They were pre-packed in bottles
and consecutively numbered for each participant accord-
ing to the randomization schedule. The protocol (Fig. 1)
included a MRI and pH-monitoring session in each study
arm on consecutive days. Due to the MRI incompatibility
of the pH monitoring device, pH studies were performed
the day after MRI following the exact same time schedule
of drug intake, test meal and body position. For GERD
patients, there was a 7 day run-in phase without PPI or
H2-Antagonists. Before each study session, subjects re-
ceived one week of pantoprazole 40 mg b.i.d. or placebo.
The two treatment arms were separated by a wash-out
phase of 7-10 days. An antacid formula was provided
(Riopan Gel®, Takeda Pharma AG, Switzerland) as rescue
medication except for the examination days.
For each session, subjects arrived after a minimum 6 h
fasting period at the study center. Study medication was
taken and 45 to 60 min later subjects drank a secretion
stimulating test meal in sitting position within 2 ± 1 min,
The test meal was designed to promote gastric secretion
and consisted of an acid stable, high caloric, viscous
chocolate drink (400 ml, 450 kcal, pH 5.4) labelled with
167.5 μM of MR contrast agent (DOTAREM®) as described
and validated previously [13].
Population
Healthy, asymptomatic subjects (HS) with no history of
digestive diseases and without reflux symptoms were
recruited by advertisement. GERD patients were recruited
from individuals referred for investigation of typical GERD
symptoms (i.e. heartburn and/or regurgitation) of at least
moderate severity (i.e. at least twice a week of at least
moderate intensity) on the Eraflux questionnaire [15, 16].
GERD was diagnosed either by endoscopy confirming an
erosive reflux disease (Stage A-C LA Classification) or
pathological esophageal acid exposure in 24 h pH-
monitoring performed within the previous 12 months
(more than 4 % < pH4 over 24 h). None had history of
upper gastrointestinal surgery. GERD patients were stud-
ied after being off acid suppressive medications for at least
7 days prior to study start. Exclusion criteria for both
groups were prior abdominal surgery (except appendec-
tomy, inguinal hernia repair), and intake of medication
other than oral contraception. A Helicobacter-13C-breath
test was performed to rule out Helicobacter pylori infec-
tion. High resolution esophageal manometry (HRM) was
performed to rule out hiatal hernia > 3 cm or esophageal
motility disorders and to measure the distance from the
nares to the lower esophageal sphincter (LOS) for pH-
probe placement.
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MRI measurements
Participants were imaged in right decubitus body pos-
ition inside a 1.5 T clinical MRI System (1.5 T Achieva,
Philips Medical Systems, The Netherlands) [13]. After a
first MRI scan in fasting condition and the intake of the
test meal, a MRI gastric volume scan followed by a vali-
dated T1-B1 mapping sequence (gastric secretion scan)
were repeatedly performed at 10 min intervals until
120 min [17]. Details on the MRI sequence parameters
of the gastric volume and secretion scans can be found
in the Additional file 1.
pH monitoring
Intragastric and esophageal pH were simultaneously mea-
sured using a 3 channel pH catheter consisting of three
ISFET probes (UNISENSOR AG, Switzerland), connected
to a pH recorder from MMS International (Medical Meas-
urement Systems B.V., The Netherlands). The three gas-
tric pH probes were located 3, 8 and 13 cm distal to the
LOS, respectively. After placement of the pH catheter, the
participants drank the test meal and spent 120 min in
right decubitus position to copy the MRI session.
Symptom scores
Symptoms were recorded before each MRI session. Heart-
burn, retrosternal pain, regurgitation and dysphagia were
assessed and graded by their weekly and daily frequency,
duration and intensity. The Eraflux score was applied to
quantify the severity of GERD. Response was defined as
an Eraflux score of <25 [15, 16].
Data analysis
MRI meal and secretion volume
Gastric content volume (GCV), meal volume (MV) and
secretion volume (SV) were derived by combining the
gastric volume and secretion data according to previ-
ously reported procedures using in-house written soft-
ware tools based on MATLAB 7.11 (The MathWorks,
USA) and IDL (Exelis Visual Information Solutions,
USA), respectively [13, 17].
In short, first the percentage of intragastric MV
(%meal) from total GCV, measured in the gastric vol-
ume scans, was calculated for each time point using the
exponential relationship between the T1 relaxation time,
measured in the gastric secretion scans and the MR con-
trast agent concentration [μM] in the meal:
%meal ¼ 100%
167:5μM
⋅
1
β
⋅ ln
T 10
T 1
 
;
with β = 0.013 μM-1 being the rate constant of the
exponential relationship and T10 = 2.58 s being the T1
relaxation time of the test meal without MR con-
trast agent. The residual fasted content volume was
negligible (17 ± 25 ml). Thus, MV = GCV · %meal
and SV =GCV - MV were then calculated and plotted over
time to generate the meal emptying and secretion curves.
Secretion concentration was defined as %secretion =
100 - %meal. Meal emptying curves were fitted using
the linear exponential (LinExp) gastric emptying model
[18]. Meal half emptying time (t50), mean SV (meanSV)
and maximum SV (maxSV) were determined.
To allow the calculation of the EGJ position relative to
the acid secretion layer, the position of the EGJ in each
gastric volume data set was extracted by selecting x-, y-
and z-coordinates of the intercept of the mid-point of
the sphincter mass with gastric content. This is illus-
trated for two different postprandial time points in the
2D MR images in Fig. 2a and the respective 3D recon-
structions of stomach and gastric content in Fig. 2b.
Gastric secretion layer
The volume and thickness of the gastric secretion layer
was extracted from the dedicated gastric secretion scans.
The layer was defined as a distinct region in the prox-
imal stomach on top of the gastric contents with %secre-
tion of ≥ 70 % (i.e. %meal of < 30 %). The 70 % secretion
threshold was chosen on the basis of in vitro experiments.
Serial dilutions of the test meal were performed with
0.1 N HCl- as a simple surrogate for gastric acid
secretions [17]. These experiments determined that
Fig. 1 Flow chart of the double blind, crossover placebo controlled study
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%secretion of ≥ 70 % (i.e. %meal of < 30 %) resulted in
pH ≤2 in the meal-secretion mixture. This conserva-
tive pH threshold is within that applied in studies
that used the pH-sensor pull-through method to de-
fine the extent of the acid pocket. Very similar results
were obtained in previous studies by titration with
gastric secretions obtained at endoscopy [10, 17].
Image processing steps for layer quantification are
depicted and explained in Fig. 3.
Contact time between gastric secretion layer and
esophagogastric junction (EGJ)
Layer-graphs (Fig. 7) were produced that integrate infor-
mation on the formation and position of the gastric secre-
tion layer from secretion scans and the EGJ position from
anatomical MRI scans (Figs. 2 and 3). The contact time
between the gastric secretion layer %secretion of ≥70 %
(i.e. %meal of < 30 %) was calculated for each subject. The
time to first occurrence of ≥70 % secretion at the EGJ was
then subtracted from the maximum recording time of
120 min to obtain the absolute period of contact time.
This result was normalized to the subject’s t50 to provide
an additional assessment of contact time that was inde-
pendent of emptying dynamics:
Relative EGJ contact timetoLayer
¼ 120 min – timetofirstLayerformationð Þ=t50
This metric describes the contact time of the EGJ with
the secretion layer relative to the gastric half emptying
time (t50). Thus, values >1 indicate that the secretion
layer was in contact for more than half the time taken to
empty the meal from the stomach. In cases where the
EGJ was not exposed to the gastric secretion layer, the
time to first occurrence of ≥70 % secretion was set to
the maximum recording time.
pH monitoring
Data from pH monitoring were visually inspected for
data quality by MS and WS using the MMS International
software tool (Medical Measurement Systems B.V., The
Netherlands). Raw data were extracted and analyzed with
home-built algorithms implemented in program R (R
Foundation for Statistical Computing, Austria). From the
three intragastric pH- probes, lowest intragastric pH
(mingastricpH) was extracted and median mingastricpH
over two hours postprandial were calculated.
Symptom scores
The severity and frequency of reflux symptoms reported
by participants were calculated using the publicly available
Eraflux score calculator (http://www.menne-biomed.de/
biomed/erascore2.html) [16].
Statistics
Statistical analyses were performed using program R
2.15./RStudio 0.98.274. The LinExp model was computed
by population non-linear mixed effect modelling using
function nlme [19]. T50 values were numerically derived
from parameters κ and tempt as described previously
Fig. 2 Definition of the EGJ position and 3D reconstruction of gastric content. a Transverse abdominal MR images at time points t = 10 and 80 min.
EGJ is marked by a white arrow. Stomach contours are depicted as yellow lines. b The 3D reconstructed contours of stomach (black closed lines) and
esophagus (dark blue closed lines) together with the color-coded gastric content (blue to red) of the same subject at the same time points. Gastric
content was color-coded to highlight the formation of the secretion layer, here depicted in red. A non-linear color-coding of the contrast optimized
grayscale values in the MR images was applied. The location of the EGJ is marked by the black dot at the end of the esophagus
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[18]. Univariate linear mixed model analysis using
function lme was applied to evaluate the effects of
study group and treatment on continuous study pa-
rameters. Eraflux scores in GERD patients under pla-
cebo and PPI were compared by a linear model using
function lm in program R. Correlation between SV
and LV was performed by linear regression also using
function lm. Parameter estimates are presented as
mean ± standard error and in case of Poisson distrib-
uted data as mean (95 % confidence interval).
Results
Participants
Twelve asymptomatic HS (8 m/4w, age 26 ± 8 years,
BMI 23 ± 2 kg/m2) and twelve GERD patients (7 m/
5w, 45 ± 11, BMI 24 ± 3 kg/m2) were recruited and all
completed the study. MRI secretion data from the
PPI arm of two GERD patients and pH data from
one HS were discarded due to technical difficulties.
Estimates ± SE for all investigated parameters are
summarized in Table 1.
MRI meal and secretion volumes
Overall maxSV was approximately 200 ml in both
groups under placebo (Table 1) with no difference be-
tween groups. PPI treatment reduced maxSV by 93 ±
20 ml in HS and 134 ± 20 ml in GERD patients, respect-
ively. No difference was observed between study groups
in either study arm, all p ≥ 0.2. Individual MV and SV
curves presented by study group and treatment are
plotted in Fig. 4. Meal emptying, as assessed by t50, was
similar in both study groups (HS vs. GERD) and was not
significantly altered by treatment (placebo vs. PPI), all
p > 0.2.
Gastric secretion layer
On placebo, gastric secretion accumulated in the prox-
imal stomach forming a distinct secretion layer on top
of the meal in 23 of 24 subjects. Variability in secretion
layer volume and thickness between subjects was large
in both study groups. On PPI, the distinct secretion layer
persisted in all but two HS and one GERD patient. Layer
formation in each subject for both treatment arms is
depicted in Fig. 5.
Layer thickness at 60 min after the meal decreased on
PPI treatment by 19 ± 1.6 mm for HS and 27 ± 1.7 mm
for GERD (p < 0.0001 in both groups), with no difference
between the study groups (both p ≥ 0.4). On placebo
there was a positive linear correlation between layer vol-
ume and secretion volume (Fig. 6). The secretion layer
(defined as ≥70 % secretions) appeared when approxi-
mately 50 ml of secretion accumulated in the stomach
and then increased in direct proportion with overall
secretion volume.
Contact time between gastric secretion layer and
esophagogastric junction (EGJ)
The layer-graphs of one healthy subject and one GERD
patient during the placebo and pantoprazole study arm
showing the EGJ position relative to the gastric secretion
Fig. 3 Schematic of post-processing steps for the quantification of acid layer thickness and volume from MR images. Gastric secretion accumulated
predominantly on the meal surface and a secretion concentration gradient was observed from the surface of the meal into the test meal
along the direction of gravity (i.e. the right side of the subject lying in the right lateral position) [10, 13]. The x-axis of the image data
was set anti-parallel to the direction of gravity. Gastric content was sliced along the x-axis using a slice thickness of 1 mm and corresponding %secretion
values were averaged along the other two Cartesian coordinates. This resulted in a 1D projection of mean %secretion values along the x-axis that was
computed for each gastric secretion scan and stacked together over time to allow visualization of the formation of the gastric secretion
layer (‘layer-graphs’). In the layer-graphs, the layer thickness was defined as the distance from the meal surface to the x coordinates having a threshold
value of ≥70 % secretion. Layer volume (LV) was calculated by summing all pixels above this threshold
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layer are depicted in Fig. 7. For placebo, normalized EGJ
contact time to the layer (≥70 % secretion) relative to
gastric half emptying time (t50) was higher in GERD
patients than HS (p = 0.012, Table 1). This indicates that
off medication the EGJ was in contact with the gastric
secretion layer for considerably more than half the gas-
tric half emptying time in GERD patients, but for only
about half of the half emptying time in HS. Absolute
exposure times were 34 ± 9 for HS and 55 ± 9 min
for GERD on placebo. PPI treatment reduced the
normalized contact time to the layer in in GERD pa-
tients (p = 0.03) and comparison between groups on
acid suppression no longer showed significant differ-
ences (p = 0.9). Absolute exposure times on PPI were
21 ± 9 for HS and 28 ± 9 min for GERD, respectively.
pH monitoring data
MingastricpH during the 2 h after the meal in HS and
GERD patients was pH 1.8 ± 0.3 and pH 1.5 ± 0.3,
respectively. MingastricpH during the 2 h postprandial
period increased under PPI in HS and GERD patients by
pH 2.7 ± 0.4 and pH 2.3 ± 0.3, respectively. No difference
was detected between study groups (placebo: p = 0.5,
PPI: p = 0.1).
Table 1 Primary and secondary outcome parameter results (data as estimate ± standard error from the lme model)
Parameter Modality HS GERD
Placebo PPI Placebo PPI
mean SV [ml] MRI 133 ± 14 73 ± 14* 152 ± 14 66 ± 14*
max SV [ml] MRI 193 ± 17 100 ± 18* 227 ± 18 94 ± 17*
Layer thickness at 60 min [mm] MRI 26 ± 5 7 ± 5* 36 ± 5 9 ± 5*
Layer Volume at 60 min [ml] MRI 79 ± 16 20 ± 16* 117 ± 17 18 ± 17*
Median mingastricph pH-monitoring 1.8 ± 0.3 4.5 ± 0.3* 1.5 ± 0.3 3.8 ± 0.3*
2 h postprandial
t50 [min] MRI 60 ± 6 71 ± 6 62 ± 6 64 ± 6
EGJ exposure time to≥ 70 % secretion
layer Normalized to T50
MRI 0.45 ± 0.2 0.42 ± 0.2 1.18 ± 0.2*** 0.42 ± 0.2**
Eraflux symptoms score Questionnaire 0 ± 0 0 ± 0 33 ± 3 20 ± 3*
* <0.05, ** p < 0.01 different to placebo
*** <0.05, p < 0.01 different to HS
Poisson distributed parameter
Fig. 4 Grouped meal and secretion volume curves. Meal Volume (MV) and Secretion Volume (SV) dynamics over 120 min for GERD patients and
Healthy Subjects (HS), under placebo (black dots/lines) and PPI (grey triangles/lines). The approximately linear emptying pattern of the test meal
is typical for a high calorie, viscous liquid meal
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Symptom scores
Symptoms improved significantly under PPI in GERD
patients. Eraflux symptom scores decreased by 13 ± 4
(p = 0.003) with 8 of 12 patients reporting a response,
defined as an Eraflux symptom score under PPI below
a score of 25 (i.e. one or less symptoms per week of
only weak intensity).
Discussion
This study applied Magnetic Resonance Imaging
(MRI) methodology to visualize and quantify the vol-
ume and distribution of gastric secretions that form a
layer in the proximal stomach after ingestion of a li-
quid meal. There was no difference in layer forma-
tion, secretion volume, intragastric pH, or gastric
emptying between healthy subjects and gastro-
esophageal reflux disease (GERD) patients on placebo.
However MRI demonstrated that the distribution of
gastric secretions in the stomach was abnormal in the
patient group such that the exposure of the EGJ to
undiluted gastric secretion was significantly more pro-
longed than in healthy controls. High dose proton
pump inhibitor (PPI) therapy reduced secretion vol-
ume, layer thickness and intra-gastric acidity in both
healthy subjects and GERD patients; however a
persistent layer of gastric secretion was still present
in the majority of individuals on acid suppression.
The first objective of this study was to test the hypoth-
esis that, compared to healthy subjects, there is either
increased volume or abnormal distribution of gastric
secretion in GERD patients. The results demonstrate
that collection of undiluted gastric secretion in the prox-
imal stomach after a meal, a key component of the “acid
pocket”, is a normal physiological phenomenon that
occurs in both healthy subjects and GERD patients [1–3,
20]. The thickness of the layer documented by MRI was
very comparable to the length of the acid pocket after
ingestion of a refluxogenic meal on pH pull-through
studies [21]. No differences were observed between the
study groups with regard to layer formation, total gastric
secretion volume or gastric emptying. However, off treat-
ment, the period of time that the EGJ was in contact
with the undiluted layer of gastric secretion was more
than twice as long in GERD patients as healthy subjects.
This confirms that it is not the volume of gastric secre-
tions per se but rather the distribution of secretions
within the proximal stomach that is abnormal in GERD
patients and that leads to prolonged exposure of the EGJ
to gastric secretions after the meal [12]. It is clear that
the proximity of undiluted gastric secretions to a weak,
Fig. 5 Formation of individual secretion layers. Layer thickness over time is depicted for all healthy subjects (HS) and GERD patients under
placebo (black dots/lines) and PPI therapy (grey triangles/lines)
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mechanically insufficient reflux barrier in such patients
will increase the risk of acid reflux. Consistent with this
view, pH-studies have shown that the presence of unbuf-
fered gastric acid adjacent to the EGJ is more important
than the size (i.e. length) of the “acid pocket” in deter-
mining the risk of reflux [1, 2]; however, in the absence
of an hiatus hernia, these studies could not explain why
this occurred. As the volume of secretions is the same in
both groups, abnormal distribution of gastric secretions
within the stomach must reflect abnormal morphology
of the EGJ and proximal stomach in GERD patients. The
three-dimensional structure and function of this region
in GERD patients has been studied by concurrent MRI
and high resolution manometry [22, 23]. This work
demonstrated that the esophagogastric insertion angle
was obtuse, the insertion of the esophagus into the
stomach and the orientation of the proximal stomach
within the abdomen are altered in GERD patients even
in the absence of hiatus hernia [24, 25]. The effect of
gastric accommodation or motility on the proximal dis-
tribution of gastric secretion was not assessed, however,
recent papers provide little evidence that accommodation
of the stomach (or intra-gastric pressure) is different in
health and GERD [24, 26].
The second objective was to document the effects
of high dose acid suppression by proton pump inhibi-
tors on the volume, distribution and acidity of the
gastric secretion layer. The findings of the random-
ized, placebo-controlled trial demonstrate that after
one week of treatment with 40 mg b.i.d. pantoprazole,
gastric secretion volume was reduced approximately
by 50 % compared to placebo (Table 1). The reduc-
tion in the volume and thickness of the layer of gas-
tric secretion above the meal and contact time with
the EGJ was even more marked, approximately 75 %
in both groups. However a distinct layer of undiluted
secretion was still visible in almost all subjects despite
high dose PPI treatment (Table 1). A recent γ-scintig-
raphy study in GERD patients quantified a reduction in
the pooling of 99mTc-pertechnetate (a surrogate for chlor-
ide ions) of 43 % and a reduction in the cross-sectional
area of the acid pocket of 33 % [12]. The larger effects on
the acid layer observed in this study can be logically ex-
plained by the three-dimensional spatial information
Fig. 6 Correlation of layer and secretion volume under placebo and PPI therapy. GERD and HS data are depicted as triangles and circles, respectively;
placebo volumes (black), PPI volumes (grey). The offset in the correlation indicates that layer formation started when approximately 50 ml
secretion was present in the stomach. For placebo, the regression coefficient was R2 = 0.7 with regression slope and offset of 1.04 ± 0.04
and -52 ± 7 ml, respectively. On pantoprazole therapy, the regression coefficient was reduced to R2 = 0.3 with regression slope and offset
of 0.56 ± 0.06 and offset -18 ± 5, respectively
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extracted from MRI data, compared to the two-
dimensional projection information obtained from γ-
scintigraphy.
Intra-gastric pH monitoring documented that the acid-
ity of the residual layer increased from below pH 2 on
placebo to pH 4.5 ± 0.3 and 3.8 ± 0.3 on PPI in healthy
subjects and GERD patients, respectively. This is very
similar to the results of previous pH pull-through studies
that documented the effects of PPI on the “acid pocket”
by pH pull-through in healthy subjects and GERD patients
[21, 27]. In summary, this study makes clear that the effect
of high-dose PPI on acid production is at least an order of
magnitude greater than its effects on gastric secretion vol-
ume (i.e. ~1 % ongoing secretion of protons (increase of 2
pH units) vs. ~50 % production of gastric secretion vol-
ume on PPI). These findings indicate that suppression of
gastric secretion is incomplete and layering of undiluted
secretion persists under PPI therapy. Although a recent
pH pull-through and γ-scintigraphy study found no differ-
ence in the position or the pH of the acid pocket between
partial and complete PPI responders [27], reasons for
symptom persistence on PPI are varied, and the persistent
layer of secretions adjacent to the EGJ seen on MRI pro-
vides a ready source of mildly acid reflux (~pH4) after
meals [1, 12]. In this situation the therapeutic aims of
GERD patients with persistent symptoms on acid suppres-
sion should not be limited to increasing intra-gastric pH
by further increasing PPI dose. Rather supplementary
therapy that involves displacing the layer of secretions
away from the EGJ as described in recent studies with
raft-forming alginates such as Gaviscon Advance (Reckitt
Benckiser, Slough, UK) may provide additional protection
from symptomatic reflux from the “acid” or, on PPI, the
“mildly-acid” pocket [5, 6, 9, 28].
Fig. 7 Layer graphs including EGJ position and time to Layer formation. Layer graphs of a healthy subject (left) and a GERD patient (right) under
placebo (top) and PPI therapy (bottom). The vertical axis represents the MR image x-axis, which is aligned along the direction of gravity.
The colours code the average %secretion. The threshold level of the layer (i.e. ≥70 % secretion) and the position of the EGJ are indicated
as white dashed and black dotted line, respectively
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This study demonstrates that combining MRI allows
non-invasive assessment of intragastric meal, secretion
and pH distribution at high spatial and temporal reso-
lution. Applied after ingestion of a secretion stimulating
test meal, this approach represents an efficient tool to
assess the efficacy of pharmaceutical agents and their
potential effect on gastric motor and secretory function
in general and the “acid pocket” in particular. Our MRI
method to assess intragastric secretion meal volumes
has been evaluated and applied in previous studies [10,
13, 17, 18, 29, 30], and has been expanded in this work
by the quantification of the secretion layer and its influence
by PPI therapy. The unique advantage of this approach is
that the distribution and layering of gastric secretion can be
visualized and analyzed locally in three-dimensions and dir-
ectly related to gastric and gastro-esophageal structure and
function. Limitations of this technique include the need to
study patients lying down in the MRI scanner rather than
in the upright position. The location of the gastric secretion
layer in the stomach and, thus, EGJ contact time with the
layer both vary with body position [31, 32]. This may be
due to the morphological changes at the EGJ that favor col-
lection of gastric secretions in this region [29]. Further,
current catheter and sensor technology for the measure-
ment of intragastric pH are not MRI compatible and, thus,
required a sequential rather than a combined measurement
protocol for MRI and pH-metry. Another issue is that
liquid nutrients do not represent a “normal meal”; however,
this is necessary to allow estimates of secretion volume and
distribution of secretion within the stomach. Note that a
previous study demonstrated no difference in acid reflux
events between liquid and solid meals with identical nutri-
tional composition [33]. A limitation of the T1 mapping
method applied to document secretion is that it does not
differentiate between gastric, duodenal or saliva secretion
(all exhibit similar T1 values) [13]. To simulate dilution of
the labelled test meal by gastric secretion and to correlate
meal dilution with intra-gastric pH, an ex vivo titration
experiment was performed using 0.1 N HCl-. A meal dilu-
tion of ≥ 70 % gastric secretion per image voxel, which
reflected a pH threshold of pH ≤ 2 off PPI, was defined as
the secretion layer. Note that, in vivo, the secretion layer
can additionally be buffered by substances such as saliva
and mucus. Otherwise, the layer pH can also contain
digestive products such as amino acids and free fatty acids
and also be contaminated by bile acids. Since simulated
gastric fluid including all mentioned factors is not yet avail-
able for in vitro digestion [34], the extent by how much
these factors may have altered the actual pH value in the
layer remains speculative. Nevertheless, the MRI approxi-
mated pH values were comparable to the actual intragastric
pH documented on sequential pH studies. An application
of the conventional threshold of pH ≤ 4 (equivalent to a
dilution of ≥17 % secretion) used to define the acid pocket
in pH pull-through studies would have had resulted in even
larger estimates of intragastric secretion volume and layer
thickness.
Conclusions
This study confirms that a layer of gastric secretion on
the surface of gastric contents is always present after
meals. The volume of gastric secretion was very similar
in healthy subjects and GERD patients; however the distri-
bution of gastric secretions in the stomach was abnormal
in GERD patients and resulted in prolonged exposure of
the EGJ to unbuffered gastric secretions. This improved
on 40 mg pantoprazole b.i.d. but layering of mildly acid
secretion at the EGJ persisted in most individuals and this
could well represent the source of mildly acid reflux that
persists in some patients on high dose PPI treatment. MRI
with T1 mapping represents a powerful non-invasive tool
for further investigations on therapies targeting the reduc-
tion of gastric secretion and reflux from the “acid pocket”.
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